HAS-BLED Score Calculator

Clinical calculation support · Verify results before clinical use

Bleeding risk assessment

Select each finding that applies. Each selected criterion contributes one point; renal and liver dysfunction can each contribute a point.

0Score / 9

Hypertension

Uncontrolled systolic blood pressure >160 mmHg.

+1 point if yes

Abnormal renal function

Chronic dialysis, renal transplantation, or serum creatinine ≥200 μmol/L (approximately 2.26 mg/dL).

+1 point if yes

Abnormal liver function

Chronic liver disease (e.g., cirrhosis) or significant biochemical liver abnormality.

+1 point if yes

Stroke history

Previous stroke.

+1 point if yes

Bleeding history or predisposition

Previous major bleeding or a bleeding predisposition, such as bleeding diathesis or anemia.

+1 point if yes

Labile INR

Unstable/high INR or poor warfarin time in therapeutic range (typically <60%). Not applicable as an INR-control measure for patients taking a DOAC.

+1 point if yes

Elderly

Age >65 years.

+1 point if yes

Drugs that increase bleeding risk

Concomitant antiplatelet therapy or NSAID use.

+1 point if yes

Excess alcohol use

Excess alcohol intake; the original score commonly operationalizes this as >8 standard drinks per week.

+1 point if yes
0HAS-BLED
Bleeding risk score interpretation
Score below high-risk threshold
0 of 9 points selected. Review the clinical context and modifiable risk factors.
Clinical action

Review blood pressure, concomitant medications, alcohol intake, and anticoagulation quality where applicable. Use clinical judgement alongside this score.

The score is a prompt for risk-factor modification and follow-up, not an individualized probability calculator. Absolute bleeding risk varies by population and clinical context.

About the HAS-BLED score

HAS-BLED was developed to estimate the risk of major bleeding over one year in patients with atrial fibrillation. It assigns one point for each criterion, with separate points for abnormal renal function, abnormal liver function, concomitant bleeding-risk drugs, and alcohol use. The maximum score is 9.

Score components

ComponentCriterionPoints
HHypertension, systolic BP >160 mmHg1
AAbnormal renal function1
AAbnormal liver function1
SPrevious stroke1
BBleeding history or predisposition1
LLabile INR / poor warfarin control1
EAge >65 years1
DConcomitant antiplatelet agent or NSAID1
DExcess alcohol use1

Interpretation and limitations

A score of ≥3 identifies patients at higher bleeding risk who may benefit from closer review and active management of modifiable factors. It should not be interpreted as a fixed annual percentage for every patient, and bleeding-risk scores should not be used alone to decide whether to initiate or withdraw anticoagulation.

  • Reassess bleeding risk as clinical status and medications change.
  • Address uncontrolled blood pressure, unnecessary antiplatelets/NSAIDs, excess alcohol, and poor warfarin control when present.
  • For patients receiving a direct oral anticoagulant, the labile-INR item generally does not apply; do not treat it as a missing point that must be replaced.

References

Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH.A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest. 2010;138(5):1093–1100. doi:10.1378/chest.10-0134.
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.European Heart Journal. 2024;45(36):3314–3414. Guidance emphasizes management of modifiable bleeding risks and advises against using bleeding scores to decide on starting or withdrawing anticoagulants. doi:10.1093/eurheartj/ehae176.
National and international clinical interpretationCriterion definitions should be applied in context, particularly for renal/liver dysfunction, bleeding predisposition, alcohol exposure, and INR control. Confirm details against the original publication and applicable local guidance.